Artemis Investment Management LLP Repligen Corp Transaction History
Artemis Investment Management LLP
- $6.19 Billion
- Q1 2025
A detailed history of Artemis Investment Management LLP transactions in Repligen Corp stock. As of the latest transaction made, Artemis Investment Management LLP holds 323,229 shares of RGEN stock, worth $36.7 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
323,229
Previous 153,832
110.12%
Holding current value
$36.7 Million
Previous $22.1 Million
85.74%
% of portfolio
0.66%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
492Shares Held
57.4MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$859 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$859 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$577 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$192 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$190 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.3B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....